Detalles de la búsqueda
1.
Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 Trials.
Medicina (Kaunas)
; 60(2)2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38399628
2.
Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis.
BMC Gastroenterol
; 23(1): 212, 2023 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37337148
3.
Chemotherapy Duration for Various Indications in Colorectal Cancer: a Review.
Curr Oncol Rep
; 25(4): 341-352, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36781622
4.
Preferred neoadjuvant therapy for gastric and gastroesophageal junction adenocarcinoma: a systematic review and network meta-analysis.
Gastric Cancer
; 25(5): 982-987, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704113
5.
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
Br J Cancer
; 125(6): 839-845, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253871
6.
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
Br J Cancer
; 124(1): 183-190, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33024268
7.
The Protein Imager: a full-featured online molecular viewer interface with server-side HQ-rendering capabilities.
Bioinformatics
; 36(9): 2909-2911, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31930403
8.
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study.
Support Care Cancer
; 29(7): 3971-3980, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392769
9.
Impact of BMI on Survival Outcomes of Immunotherapy in Solid Tumors: A Systematic Review.
Int J Mol Sci
; 22(5)2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33807855
10.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
11.
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.
Br J Cancer
; 123(3): 403-409, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32424148
12.
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab.
Gastric Cancer
; 23(6): 1064-1074, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32372141
13.
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
BMC Cancer
; 19(1): 283, 2019 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30922323
14.
Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis.
Gastric Cancer
; 22(2): 245-254, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30483986
15.
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma.
Future Oncol
; 15(16): 1811-1822, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30969136
16.
Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.
Oncology
; 94(4): 191-199, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29393280
17.
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.
Oncology
; 95(6): 344-352, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30130791
18.
Right Versus Left Colon Cancer: Resectable and Metastatic Disease.
Curr Treat Options Oncol
; 19(6): 31, 2018 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29796712
19.
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Oncologist
; 22(12): 1463-1469, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28860412
20.
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
N Engl J Med
; 371(17): 1609-18, 2014 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25337750